Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Dividend declared
Appointed CFO
Quarterly results
CC transcript
Inv. presentation
|
|
ARES CAPITAL CORP (ARCC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/20/2019 |
GN
| Analysis: Positioning to Benefit within Jacobs Engineering Group, Ares Capital, CytomX Therapeutics, FuelCell Energy, Timken, and Farmland Partners — Research Highlights Growth, Revenue, and Consolidated Results |
| 10/05/2018 |
GN
| Detailed Research: Economic Perspectives on CDK Global, Buckle, Argan, Ares Capital, TAL Education Group, and Monster Beverage — What Drives Growth in Today's Competitive Landscape |
| 06/27/2018 |
GN
| Detailed Research: Economic Perspectives on Comerica, Vanda Pharmaceuticals, Acadia Healthcare, The Charles Schwab, Ares Capital, and EQT — What Drives Growth in Today's Competitive Landscape |
| 05/11/2018 |
GN
| Recent Analysis Shows Ares Capital, The Middleby, Cardtronics, NOW, Coca-Cola European Partners, and News Corporation Market Influences — Renewed Outlook, Key Drivers of Growth |
| 02/08/2018 |
GN
| New Research: Key Drivers of Growth for Radian Group, Flexion Therapeutics, Andeavor, Haverty Furniture Companies, Ares Capital, and Sempra Energy — Factors of Influence, Major Initiatives and Sustained Production |
| 11/17/2017 |
GN
| Consolidated Research: 2018 Summary Expectations for Realogy, Calgon Carbon, Pioneer Natural Resources, Veeva, Ares Capital, and Sempra Energy — Fundamental Analysis, Key Performance Indications |
|
|